In March 2017, the FDA approved the use of dupilumab (Dupixent), an antibiotic that helps lower inflammation, for eczema. Doctors use this drug to help treat moderate to severe eczema. Clinical ...
The U.S. Food and Drug Administration (FDA) has approved the granule formulation of Neurocrine Biosciences' (NBIX.O) , opens new tab Ingrezza drug to treat movement disorders associated with ...
The US Food and Drug Administration (FDA) has approved the biosimilar ustekinumab-aekn (Selarsdi) for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis in adults and ...
Instead, Galiatsatos said, the FDA approved the drug based on other signs of effectiveness, including whether patients were able to walk farther in six minutes than they could before they started ...
The FDA has approved a first-in-class bladder cancer drug. Anktiva (interleukin (IL)-15 superagonist nogapendekin alfa inbakicept-pmln) administered with bacillus Calmette-Guérin was approved for ...
FDA Approves Clobazam Add-On for Lennox Syndrome The benzodiazepine is already available in 100 other countries, marketed under different brand names. News, October 24, 2011 Orphan Drug Status for ...
(CNN) – The U.S. Food & Drug Administration has approved the first ... of non-alcoholic fatty liver disease. According to the FDA, about six to eight million people in the U.S. are thought ...
director of the anti-infectives unit at the FDA's Center for Drug Evaluation and Research. Advertisement "The FDA is committed to fostering new antibiotic availability when they prove to be safe ...
Opens in a new tab or window The FDA approved mavorixafor (Xolremdi ... should be monitored for QTc interval prolongation. The drug is not recommended for those with severe renal or hepatic ...
The Food and Drug Administration has approved a Boston ... In most patients, WHIM syndrome is caused by mutations in the CXCR4 gene. The FDA approval was based on the results of a late-stage ...
The drug is combined with the BCG vaccine, mainly used against tuberculosis and as a common treatment for some forms of bladder cancer. Last year in May, the FDA issued a complete response ...